U.S. Paper and Forestry Products Stock News

Abbott Laboratories (NYSE:ABT) is acquiring cancer diagnostics company Exact Sciences in a deal financed by a US$20b bond sale. The transaction marks Abbott's entry into oncology diagnostics, expanding its presence in higher growth testing and screening markets. The large bond issuance is set to reshape Abbott's capital structure and raises fresh questions about risk, return and balance sheet flexibility. Abbott Laboratories, trading at around US$114.76, is moving beyond its traditional...

CCC Intelligent Solutions Holdings (CCCS) closed FY 2025 with Q4 revenue of US$277.9 million and basic EPS of US$0.01, while trailing twelve month figures show revenue of US$1.1 billion and basic EPS of essentially breakeven at US$0.00. Over recent quarters the company has seen revenue move from US$246.5 million in Q4 2024 to US$277.9 million in Q4 2025, with quarterly EPS ranging between a loss of US$0.03 and a profit of US$0.02. For investors, the latest print puts the spotlight squarely on...

If you are looking at Comcast and wondering whether the current share price reflects its underlying value, this article will walk you through what the numbers are really saying about the stock. Comcast shares recently closed at US$30.79, with returns of 4.6% over the last 30 days, 4.2% year to date, and a 1 year return of a 2.5% decline alongside a 5 year return of a 29.2% decline. Recent headlines around Comcast have focused on its position as a major US telecom and media company, including...

If you are wondering whether Novo Nordisk’s recent share price slump has created a potential opportunity or a value trap, you are in the right place. The stock last closed at US$38.16, after declines of 22.5% over 7 days, 40.4% over 30 days, and 27.2% year to date, with a 56.5% decline over 1 year and a softer 44.6% return over 3 years compared to a 13.5% gain over 5 years. These moves come as Novo Nordisk remains in the spotlight for its role in weight management and diabetes treatments...

What Sify Technologies (SIFY) Investors Might Be Watching Now Sify Technologies (SIFY) has quietly caught investor attention after a very large 1 year total return of 238%, alongside an 81% gain over the past month and 48% over the past 3 months. See our latest analysis for Sify Technologies. With the share price now at US$16.20, Sify Technologies has moved sharply over the past year, as a very large 1 year total shareholder return contrasts with a shorter term share price pullback and...

If you are wondering whether Kosmos Energy is still attractively priced after recent moves, this article walks through what the numbers actually say about its current value. The stock last closed at US$2.09, with returns of 22.9% over the past week, 64.6% over the past month and 134.1% year to date, while the 1 year, 3 year and 5 year returns stand at 21.1% decline, 72.9% decline and 35.9% decline respectively. Recent price action has come alongside ongoing investor interest in the US energy...

CACI International (CACI) is drawing fresh investor attention after its Spectral program with the U.S. Navy reached Milestone C. This clears the way for low rate initial production and deployment of its electronic warfare technology. See our latest analysis for CACI International. Alongside the Spectral milestone and upcoming investor conference appearance, CACI’s 1-year total shareholder return of 78.22% and 5-year total shareholder return of 172.69% contrast with its recent 30-day share...

If you are wondering whether Smithfield Foods is trading at an attractive price or if the recent buzz has left it looking fully priced, this article walks through the key numbers that matter. Over the past week the stock recorded a 0.4% decline, while the 30 day return sits at 4.2%, the year to date return at 10.7%, and the 1 year return at 24.6%. This has put valuation firmly on investors' radar. Recent attention on Smithfield Foods has centered on company specific developments and sector...

Rocky Brands (RCKY) FY 2025 earnings snapshot Rocky Brands (RCKY) closed FY 2025 with fourth quarter revenue of US$139.7 million and basic EPS of US$0.87, supported by trailing twelve month revenue of US$482.0 million and EPS of US$2.98 as the latest earnings release hit the tape. The company has seen quarterly revenue move from US$128.1 million and EPS of US$0.64 in Q4 2024 to US$139.7 million and US$0.87 in Q4 2025. Net profit margin over the last 12 months sits at 4.6% compared with 2.5% a...

Pinterest (NYSE:PINS) is overhauling its sales and go to market approach, with management spotlighting new monetization efforts. The company is bringing in new board members to deepen its commerce and advertising capabilities. Leadership is positioning these changes as a pivot that could reshape how Pinterest turns user engagement into revenue. Pinterest sits at the intersection of visual discovery, shopping intent, and digital advertising. This keeps it closely linked to how brands spend...

Setting the stage after recent trading moves Amneal Pharmaceuticals (AMRX) has drawn fresh attention after recent trading moves, with the stock closing around $14.58 and showing mixed short term returns along with positive performance over the past 3 months and year. See our latest analysis for Amneal Pharmaceuticals. While the 1-day and 7-day share price returns show a small pullback, the 30-day and 90-day share price returns, together with a very large 3-year total shareholder return,...

eToro Group (NasdaqGS:ETOR) released new survey findings on Gen Z and millennial retail investors. The survey shows younger investors are spreading capital across bonds, foreign equities, real estate, cryptocurrencies, and commodities. The results point to broader diversification beyond the meme stock trading that drew attention in earlier years. eToro operates as a multi asset investing platform, giving retail investors access to a wide range of securities and asset classes in a single...

Why Palvella Therapeutics Has Caught Investor Attention Recent trading in Palvella Therapeutics (PVLA) has drawn attention after a sharp share price move, with the stock closing at US$128.60 and posting very large 1 year total returns. That type of performance, together with reported annual revenue growth of 63.12% and net income growth of 54.52% on a net loss of US$32.37 million, is prompting investors to reassess how they view this clinical stage biopharmaceutical name. See our latest...

Veracyte, ticker NasdaqGM:VCYT, plans to present more than 15 abstracts from its urology portfolio at the 2026 ASCO Genitourinary Cancers Symposium. The company is preparing to launch its TrueMRD test for muscle invasive bladder cancer and continues to build out its broader genomic testing offerings. Veracyte enters this news cycle with its shares at $35.72 and a mixed return profile, including a 50.7% gain over three years alongside a 15.7% decline year to date and a 12.0% decline over the...

AXIS Capital Holdings (NYSE:AXS) announced the retirement of board member Thomas Ramey. His retirement represents a change in the company’s board-level governance structure. For you as an investor, board changes at an insurer like AXIS Capital Holdings matter because they sit close to decisions on risk appetite, capital allocation and long term priorities. The company operates in specialty insurance and reinsurance, areas that can be influenced by evolving regulation and changing views on...

HF Sinclair (DINO) has moved within a relatively tight range recently, with a 1 day return of 0.4% and a month gain of about 1%, while the past 3 months show a 4.6% decline. See our latest analysis for HF Sinclair. At a share price of $49.86, HF Sinclair’s shorter term momentum looks softer, with a 7 day share price return showing a decline of 3.32% and a 90 day share price return showing a decline of 4.56%, while its 1 year total shareholder return of 51.9% points to much stronger gains over...

If you are wondering whether Veeva Systems at around US$176 per share still offers solid value, you are not alone. This article is built to help you frame that question clearly. The stock has seen a 21.3% decline over the last 30 days and is down 22.3% over the past year, which may have shifted how the market views its growth potential and risk profile. Recent coverage has focused on Veeva Systems' role as a key software provider to life sciences companies and how its customer relationships...

Wayfair Inc. reported full-year 2025 results showing sales of US$12.46 billion, up from US$11.85 billion, while reducing its net loss to US$313 million and loss per share to US$2.44 compared with the prior year. Despite delivering revenue growth and narrowing losses, the company’s return to a GAAP net loss and signals of ongoing margin pressure raised fresh questions about the durability of its profitability efforts. Next, we will examine how these margin concerns and renewed GAAP losses...

AMC Entertainment Holdings (AMC) is back in focus after Muvico, a wholly owned subsidiary, launched a US$1.73b first lien notes offering tied to a new US$750m term loan and broader refinancing plans. See our latest analysis for AMC Entertainment Holdings. That refinancing announcement lands after a tough stretch for holders, with the share price at US$1.16 and recent moves including a 22.15% 30 day share price decline and a 64.42% 1 year total shareholder return loss, suggesting momentum has...

Why TXNM Energy Is On Investors’ Radar TXNM Energy (TXNM) has been drawing attention after its recent rebranding from PNM Resources, reflecting its focus on regulated electricity generation, transmission, and distribution across New Mexico and Texas. See our latest analysis for TXNM Energy. At a share price of $59.44, TXNM’s short term share price returns have been relatively muted. However, the 1 year total shareholder return of 18.39% and 5 year total shareholder return of 47.90% point to...

WaterBridge Infrastructure (NYSE:WBI) has announced the initiation of its first quarterly dividend, marking a new approach to capital returns. The company has also launched the open season for its Speedway Phase II Pipeline project, inviting commercial commitments for new capacity. Both announcements were released together as part of a broader update on corporate priorities and capital allocation. For investors following NYSE:WBI, these developments relate directly to how the company is...

The Trump administration’s new 15% global tariff, set for up to 150 days, has put fresh attention on Brunswick (BC). The stock fell 7.1% as investors reassessed trade sensitive exposure. See our latest analysis for Brunswick. That tariff driven 1 day share price decline of 3.35%, alongside a 9.26% 7 day and 5.50% 30 day share price pullback, comes after a stronger 21.62% 90 day share price return and 33.04% 1 year total shareholder return. This suggests recent momentum has cooled even as...

Event context and recent stock move Dollar General (DG) has drawn fresh attention after a period of strong share price performance, with the stock showing a return of about 42% over the past 3 months. For investors, that move naturally raises questions about how the current price lines up with the company’s fundamentals, including profitability and overall value profile. See our latest analysis for Dollar General. Looking beyond the recent 3 month share price return, Dollar General’s latest...

On February 19, 2026, Zurn Elkay Water Solutions’ subsidiaries entered into Amendment No. 3 to their first lien credit agreement, refinancing existing revolving borrowings, expanding the revolving credit facility from US$200,000,000 to US$550,000,000, and extending the facility’s maturity to February 19, 2031. The revised agreement, which ties interest margins and fees to net first lien leverage and boosts remaining borrowing capacity to US$540,100,000, materially increases Zurn Elkay’s...